The AML-Associated A338V Mutation Rewires GPR183 Signaling through C-Terminal Ensemble Redistribution.
5 affiliations
- 1Molecular Pharmacology of GPCRs, Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Stockholm171 65, Sweden.
- 2Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CambridgeCB2 1EW, United Kingdom.
- 3Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, South Parks Road, OxfordOX1 3QZ, United Kingdom.
- 4Department of Theoretical Chemistry, University of Gdansk, Wita Stwosza 63, Gdansk80-308, Poland.
- 5Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul06351, Korea.
Abstract
G protein-coupled receptors (GPCRs) rely on dynamic conformational ensembles to coordinate G protein activation and recruitment of regulatory transducers such as GPCR kinases and β-arrestins. The oxysterol receptor GPR183 has been implicated in hematological malignancies, including acute myeloid leukemia (AML), where a rare A338V substitution occurs within its intrinsically disordered C-terminal tail. Here, we combined bioluminescence/fluorescence resonance energy transfer, bioluminescence- and fluorescence-based assays as well as migration experiments, with molecular dynamics simulations and allosteric communication networks to define the structural and functional consequences of this mutation. The A338V variant preserved agonist potency and largely maintained or even enhanced agonist-induced Gi protein activation, likely by inducing different receptor core conformations. On the other hand, it consistently impaired GRK2 and β-arrestin2 recruitment across multiple experimental configurations. Atomistic simulations supported these observations and further suggested that A338V reshapes the conformational ensemble of the C-terminal tail, altering its disorder, compaction, and membrane interactions. In particular, the mutation redistributes lipid interactions of phosphorylation-prone serine and threonine residues within the tail, suggesting disrupted spatial presentation of regulatory motifs required for productive GRK2 and β-arrestin coupling. Importantly, overexpression of GPR183 A338V in differentiated HL-60 cells led to a significant increase in migration of these cells toward the chemoattractant. Together, these results identify the intrinsically disordered C-terminal tail of GPR183 as a determinant of selective transducer coupling and show how a single naturally occurring mutation within a GPCR intrinsically disordered region can alter its conformational ensemble, selectively modulate intracellular protein coupling, and affect receptor-mediated cellular behavior.
Related
- X-ray structure of the human Nijmegen breakage syndrome forkhead-associated/BRCA1 C-terminal domain and computational docking of candidate radiosensitizers
- Identification of expressed endogenous retroviral element associated long terminal repeats in devil facial tumour cells
- Cryo-EM Reveals VP1/VP2 N-Terminal Conformations in Adeno-Associated Virus 2 Capsids.
- The ITM2B-associated retinal dystrophy mutation modifies BRI23 peptide interactions in the human retina
- Fecal microbiota profiles and targeted qPCR markers associated with the need for therapeutic ascites drainage in patients with terminal pancreatic cancer: an exploratory study
BibTeX
@article{andersson2026amlassociated,
title = {{The AML-Associated A338V Mutation Rewires GPR183 Signaling through C-Terminal Ensemble Redistribution.}},
author = {Louise Andersson and Patryk A Wesołowski and Laura Jahrstorfer and Alexander De Rosa and Tomáš Heger and Vilmos Neuman and Adam K Sieradzan and David J Wales and Paweł Kozielewicz},
journal = {Journal of the American Chemical Society},
year = {2026},
month = oct,
doi = {10.1021/jacs.6c10287},
url = {https://europepmc.org/article/MED/42912320},
note = {CC BY},
}
RIS
TY - JOUR
TI - The AML-Associated A338V Mutation Rewires GPR183 Signaling through C-Terminal Ensemble Redistribution.
AU - Louise Andersson
AU - Patryk A Wesołowski
AU - Laura Jahrstorfer
AU - Alexander De Rosa
AU - Tomáš Heger
AU - Vilmos Neuman
AU - Adam K Sieradzan
AU - David J Wales
AU - Paweł Kozielewicz
PY - 2026
DA - 2026/10/01
JO - Journal of the American Chemical Society
DO - 10.1021/jacs.6c10287
UR - https://europepmc.org/article/MED/42912320
AB - G protein-coupled receptors (GPCRs) rely on dynamic conformational ensembles to coordinate G protein activation and recruitment of regulatory transducers such as GPCR kinases and β-arrestins. The oxysterol receptor GPR183 has been implicated in hematological malignancies, including acute myeloid leukemia (AML), where a rare A338V substitution occurs within its intrinsically disordered C-terminal tail. Here, we combined bioluminescence/fluorescence resonance energy transfer, bioluminescence- and fluorescence-based assays as well as migration experiments, with molecular dynamics simulations and allosteric communication networks to define the structural and functional consequences of this mutation. The A338V variant preserved agonist potency and largely maintained or even enhanced agonist-induced Gi protein activation, likely by inducing different receptor core conformations. On the other hand, it consistently impaired GRK2 and β-arrestin2 recruitment across multiple experimental configurations. Atomistic simulations supported these observations and further suggested that A338V reshapes the conformational ensemble of the C-terminal tail, altering its disorder, compaction, and membrane interactions. In particular, the mutation redistributes lipid interactions of phosphorylation-prone serine and threonine residues within the tail, suggesting disrupted spatial presentation of regulatory motifs required for productive GRK2 and β-arrestin coupling. Importantly, overexpression of GPR183 A338V in differentiated HL-60 cells led to a significant increase in migration of these cells toward the chemoattractant. Together, these results identify the intrinsically disordered C-terminal tail of GPR183 as a determinant of selective transducer coupling and show how a single naturally occurring mutation within a GPCR intrinsically disordered region can alter its conformational ensemble, selectively modulate intracellular protein coupling, and affect receptor-mediated cellular behavior.
SN - 0002-7863
SN - 1520-5126
ER -